EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

An Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial

Jacob E Kurlander, Danielle Helminski, Xueting Tao, Sameer D Saini, Sarah L Krein, Caroline R Richardson, Kelley M Kidwell, Michael S M Lanham, Jennifer L Henstock, Jesse Resnick, Michael Song, Raymond De Vries und 6 weitere

Thrombosis and Haemostasis · 01.08.2025 · 125 (08) · 733-743

DOI: 10.1055/a-2544-6104 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2025. Verfasst von Jacob E Kurlander und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States. Hauptthemen laut MEDLINE: Warfarin, Platelet Aggregation Inhibitors, Anticoagulants, Gastrointestinal Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many patients receiving anticoagulants take antiplatelet medications unnecessarily and without gastroprotection, increasing the risk of gastrointestinal bleeding. To evaluate the effectiveness of a multicomponent intervention—clinician notification with nurse facilitation (CNNF)—in reducing high-risk use of antiplatelet medications in patients taking warfarin without a proton pump inhibitor (PPI). For patients in the CNNF group, nurses sent electronic messages to clinicians identifying patients with high-risk antiplatelet use, recommending consideration of either antiplatelet discontinuation or PPI initiation, and offering to facilitate any medication changes. The primary outcome was the percentage of patients who self-reported either discontinuing antiplatelet therapy or initiating a PPI at 7 to 10 weeks. The secondary outcome was the percentage of patients with a documented clinician recommendation to make such a medication change. Among 220 patients, CNNF was associated with increased odds of discontinuing antiplatelet therapy or initiating a PPI in the intention-to-treat analysis (adjusted odds ratio [aOR] 5.76, 95% CI 2.54, 13.05). The effect was stronger in a modified completer analysis (n = 126, aOR 43.6, 95% CI 6.56, 289.88). The intervention was also associated with increased odds of a clinician recommendation for a medication change (75/110 [68.2%] versus 1/110 [0.9%], log aOR 19.86, 95% CI 10.63, 29.09). Surgeons and proceduralists were less likely to recommend medication changes relative to other clinicians (log aOR −16.08, 95% CI −23.34, −8.82). The multicomponent intervention effectively led to antiplatelet discontinuation or PPI initiation in patients initially prescribed warfarin-antiplatelet therapy without gastroprotection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinPlatelet Aggregation InhibitorsAnticoagulantsGastrointestinal HemorrhageHumansFemaleMaleAgedProton Pump InhibitorsMiddle AgedRisk FactorsAged, 80 and overTreatment Outcome

Substanzen

WarfarinPlatelet Aggregation InhibitorsAnticoagulantsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States.
  • Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, United States.
  • Veterans Affairs (VA) Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan, United States.
  • Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, United States.
  • Department of Family Medicine, Brown University, Providence, Rhode Island, United States.
  • Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan, United States.

ORCID-Profile: Geoffrey D Barnes

Förderung

  • HSRD VA
  • NIDDK NIH HHS

Zitieren

APA

Kurlander, J. E., Helminski, D., Tao, X., Saini, S. D., Krein, S. L., Richardson, C. R., Kidwell, K. M., Lanham, M. S. M., Henstock, J. L., Resnick, J., Song, M., Vries, R., Resnicow, K., Ha, N., Haymart, B., Alexandris-Souphis, C., Froehlich, J. B., & Barnes, G. D. (2025). An Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial. Thrombosis and Haemostasis, 125(08), 733-743. https://doi.org/10.1055/a-2544-6104

Vancouver

Kurlander JE, Helminski D, Tao X, Saini SD, Krein SL, Richardson CR, et al. An Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial. Thrombosis and Haemostasis. 2025;125(08):733-743. doi:10.1055/a-2544-6104

BibTeX
@article{Kurlander2025,
  author = {Kurlander, Jacob E and Helminski, Danielle and Tao, Xueting and Saini, Sameer D and Krein, Sarah L and Richardson, Caroline R and Kidwell, Kelley M and Lanham, Michael S M and Henstock, Jennifer L and Resnick, Jesse and Song, Michael and Vries, Raymond De and Resnicow, Kenneth and Ha, Nghi and Haymart, Brian and Alexandris-Souphis, Constantina and Froehlich, James B and Barnes, Geoffrey D},
  title = {An Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {08},
  pages = {733--743},
  doi = {10.1055/a-2544-6104}
}
Kostenlos starten →